Edition:
India

miRagen Therapeutics Inc (MGEN.OQ)

MGEN.OQ on NASDAQ Stock Exchange Capital Market

3.48USD
16 Nov 2018
Change (% chg)

$0.13 (+3.88%)
Prev Close
$3.35
Open
$3.30
Day's High
$3.54
Day's Low
$3.09
Volume
78,058
Avg. Vol
30,943
52-wk High
$10.68
52-wk Low
$3.09

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -0.31 December 17 Nov 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 3 3
(2) OUTPERFORM 2 2 2 3
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.40 1.40 1.40 1.50

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 3 1.54 1.94 1.10 1.16
Quarter Ending Mar-19 2 1.38 1.40 1.35 0.72
Year Ending Dec-18 4 9.29 9.85 8.80 3.16
Year Ending Dec-19 4 4.22 5.78 0.00 0.96
Earnings (per share)
Quarter Ending Dec-18 4 -0.31 -0.28 -0.32 -0.46
Quarter Ending Mar-19 3 -0.34 -0.32 -0.37 --
Year Ending Dec-18 4 -1.07 -1.05 -1.09 -1.58
Year Ending Dec-19 4 -1.50 -1.14 -1.98 -1.81

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 1.89 0.94 0.95 50.16
Quarter Ending Jun-18 0.83 2.18 1.35 161.63
Quarter Ending Mar-18 1.17 4.78 3.61 307.84
Quarter Ending Dec-17 1.34 1.19 0.15 11.29
Quarter Ending Sep-17 0.31 1.63 1.33 433.01

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 1.54 1.96 2.04 2.04 1.16
Quarter Ending Mar-19 1.38 1.08 0.80 0.80 0.72
Year Ending Dec-18 9.29 9.46 9.93 9.93 3.16
Year Ending Dec-19 4.22 5.46 5.46 5.46 0.96

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 0 1 1 2
Quarter Ending Mar-19 1 0 1 0
Year Ending Dec-18 1 1 1 2
Year Ending Dec-19 0 1 0 1
Earnings